英文名稱 | Crizotinib (PF-02341066) |
---|---|
中文名稱 | 克唑替尼 |
CAS號(hào) | 877399-52-5 |
分子式 | C21H22Cl2FN5O |
分子量 | 450.34 |
外觀 | White to light brown powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
---|---|---|---|---|
50 mg | 3-5days | ¥450.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥720.00 | 登錄后可見(jiàn) | |
250 mg | 3-5days | ¥1152.00 | 登錄后可見(jiàn) |
英文名稱 | Crizotinib (PF-02341066) |
---|---|
中文名稱 | 克唑替尼 |
CAS號(hào) | 877399-52-5 |
分子式 | C21H22Cl2FN5O |
分子量 | 450.34 |
外觀 | White to light brown powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Crizotinib (formerly known as PF-02341066; trade name: Xalkori) is a potent, orally bioavailable small molecule inhibitor of c-Met and ALK that is bioavailable when taken orally. In assays based on cells, it inhibits c-Met and ALK with IC50 values of 11 nM and 24 nM, respectively.